Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02781519

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.

Conditions

Interventions

TypeNameDescription
DRUGTHCActive THC (0.015mg/kg) administered over 10 minutes
DRUGPlaceboControl: small amount of alcohol (quarter teaspoon), with no THC over 10 minutes

Timeline

Start date
2015-06-01
Primary completion
2026-06-01
Completion
2026-12-01
First posted
2016-05-24
Last updated
2025-06-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02781519. Inclusion in this directory is not an endorsement.

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans (NCT02781519) · Clinical Trials Directory